The FDA denied Henry Ford Health System's request for an emergency use authorization for hydroxychloroquine for a segment of COVID-19 patients.
In a statement, Henry Ford said the decision does not impact the ongoing study that investigates hydroxychloroquine as a preventative treatment.
"At the same time, we remain focused on advancing efforts to develop a safe and effective vaccine against COVID-19," Henry Ford said. "We are the only site in Michigan enrolling volunteers in the phase 3 trial of the Moderna mRNA-1273 Coronavirus vaccine and evaluating its promise as a vaccine candidate. We continue to believe that a safe and effective vaccine is the best way to protect people from this devastating virus."
Dr. Anthony Fauci previously called the study on the effectiveness of using hydroxychloroquine to treat COVID-19 "flawed" during testimony in front of a House subcommittee.
In response, doctors at Henry Ford Health System penned an open letter, saying the current political climate has made any discussion of the drug impossible.
